FRQKX Performance — Fidelity Managed Retirement 2010 Fund, Class K
Data updated: 2026-06-26
FRQKX returned +2.70% year to date and +9.92% over one year to Apr 2026. Annualised returns are +7.12% over 3 years and +2.89% over 5 years. The fund trailed its Target-Date category average: $100 invested three years ago grew to $123, against $149 for the category, and to $110 over one year, against $122. Volatility over the past three years was 5.49% a year. In the 12 months to Apr 2026 the fund lost a net $2.3M, and assets reached $5.11M.
FRQKX Growth of $100
What $100 invested in Fidelity Managed Retirement 2010 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | FRQKX | Category average |
|---|---|---|
| 1 year (May 2025 – Apr 2026) | $110 | $122 |
| 3 years (May 2023 – Apr 2026) | $123 | $149 |
| 5 years (May 2021 – Apr 2026) | $115 | $141 |
| Since data start (Sep 2019 – Apr 2026) | $133 | $182 |
FRQKX Trailing Returns
Total returns to Apr 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +2.70% |
| 1 year | +9.92% |
| 3 years (annualised) | +7.12% |
| 5 years (annualised) | +2.89% |
FRQKX Annual Returns
Calendar-year total returns of Fidelity Managed Retirement 2010 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Apr) | +2.70% |
| 2025 | +10.10% |
| 2024 | +4.57% |
| 2023 | +8.60% |
| 2022 | −12.31% |
| 2021 | +3.94% |
| 2020 | +9.67% |
| 2019 (Sep–Dec) | +3.27% |
FRQKX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.1% | +1.6% | −2.5% | +2.4% | — | — | — | — | — | — | — | — |
| 2025 | +1.3% | +1.4% | −0.4% | +0.6% | +0.8% | +1.9% | +0.1% | +1.4% | +1.4% | +0.8% | +0.3% | +0.2% |
| 2024 | −0.1% | +0.2% | +1.4% | −2.0% | +2.0% | +0.9% | +1.8% | +1.3% | +1.5% | −2.0% | +1.3% | −1.6% |
| 2023 | +3.9% | −2.2% | +2.2% | +0.6% | −1.0% | +1.0% | +0.9% | −1.1% | −2.3% | −1.5% | +4.6% | +3.5% |
| 2022 | −2.0% | −1.3% | −1.2% | −3.8% | +0.3% | −3.4% | +3.0% | −2.5% | −5.3% | +0.6% | +4.5% | −1.5% |
| 2021 | −0.1% | +0.1% | −0.2% | +1.6% | +0.7% | +0.7% | +0.6% | +0.5% | −1.3% | +1.3% | −0.8% | +0.7% |
| 2020 | +0.2% | −1.1% | −5.1% | +3.5% | +1.8% | +1.7% | +2.5% | +1.4% | −0.7% | −0.6% | +4.0% | +1.9% |
| 2019 | — | — | — | — | — | — | — | — | +0.2% | +1.1% | +0.7% | +1.3% |
FRQKX Risk
Risk measures from monthly returns over May 2023 – Apr 2026.
- 3-year volatility (annualised): 5.49%
- 3-year Sharpe ratio: 0.48 (vs 4.5% risk-free rate)
- Best month: +4.61% (Nov 2023)
- Worst month: −2.45% (Mar 2026)
FRQKX Fund Flows
Monthly money in and out of Fidelity Managed Retirement 2010 Fund, from SEC Form N-PORT.
- 12-month net flow: −$2.3M
- 12-month gross sales (incl. reinvestments): $1.9M
- Sales ÷ redemptions: 0.45×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Apr 2026 | $9K | $1.4M | −$1.4M |
| Mar 2026 | $261K | $1.1M | −$798K |
| Feb 2026 | $121K | $193K | −$72K |
| Jan 2026 | $613K | $610K | $2K |
| Dec 2025 | $86K | $57K | $29K |
| Nov 2025 | $34K | $185K | −$151K |
| Oct 2025 | $17K | $119K | −$102K |
| Sep 2025 | $50K | $23K | $27K |
| Aug 2025 | $115K | $226K | −$112K |
| Jul 2025 | $10K | $6K | $4K |
| Jun 2025 | $103K | $183K | −$80K |
| May 2025 | $490K | $178K | $312K |
FRQKX Assets Under Management
Net assets of Fidelity Managed Retirement 2010 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-04-30 | $5.11M |
| 2026-01-31 | $7.30M |
| 2025-10-31 | $7.42M |
| 2025-07-31 | $7.39M |
| 2025-04-30 | $6.99M |
| 2025-01-31 | $5.35M |
| 2024-10-31 | $6.80M |
| 2024-07-31 | $5.50M |
| 2024-04-30 | $5.66M |
| 2024-01-31 | $6.18M |
| 2023-10-31 | $5.85M |
| 2023-07-31 | $6.17M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.